FDMT
4D Molecular Therapeutics Appoints Carolyne Zimmermann as Chief Business Officer
Monday, June 7, 2021 1 min read
Key Takeaway: 4D Molecular Therapeutics Appoints Carolyne Zimmermann as Chief Business Officer
Full Press Release Details
4D Molecular Therapeutics Appoints Carolyne Zimmermann as Chief Business Officer.